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Summary
Indomethacin (IMC) is an analgesic drug whose physicochemical properties have 
not been thoroughly studied. In this work the Extended Hildebrand Solubility 
Approach (EHSA) was applied to evaluate the solubility of IMC in ethanol + water 
mixtures at 298.15 K. An acceptable correlative capacity of EHSA was found using 
a regular polynomial model in order four (overall deviation lower than 4.1%), when 
the W interaction parameter is related to the solubility parameter of the mixtures. 
Besides, the deviations obtained in the estimated solubility with respect to experi-
mental solubility were lower compared with those obtained directly by means of 
an empiric regression of the experimental solubility as a function of the mixtures’ 
solubility parameters.
Key words: Binary mixtures, Extended Hildebrand Solubility Approach, Indo-
methacin, Solubility parameter.
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Resumen
Método extendido de Hildebrand en la estimación de la 
solubilidad de la indometacina en mezclas etanol + agua
La indometacina (IMC) es un analgésico cuyas propiedades fisicoquímicas aún no 
han sido totalmente estudiadas. En la presente investigación, se aplicó el Método 
Extendido de Solubilidad de Hildebrand (MESH) al estudio de la solubilidad de la 
IMC en mezclas binarias etanol + agua a 298,15 K. Se obtuvo una capacidad predic-
tiva aceptable del MESH (desviación general inferior al 4,1%) al utilizar un modelo 
polinómico regular de cuarto orden relacionando el parámetro de interacción W con 
el parámetro de solubilidad de las mezclas solventes. De esta forma, las desviaciones 
obtenidas en la solubilidad estimada, fueron de magnitud inferior a las obtenidas al 
calcular esta propiedad directamente, utilizando una regresión empírica regular del 
mismo orden, de la solubilidad experimental del fármaco en función del parámetro 
de solubilidad de las mezclas disolventes.
Palabras clave: Indometacina, Método Extendido de Solubilidad de Hildebrand, 
Mezclas binarias, Parámetro de solubilidad.
Introduction
Indomethacin (IMC, Fig. 1) is a non-steroidal anti-inflammatory drug used as analge-
sic and antipyretic, among other indications (1, 2). In the Colombian market this drug 
is available as capsules, oil ophthalmic drops, and injectable powder for reconstitution 
intended to intramuscular administration, but it is not available as any homogeneous 
liquid dosage form (3). Although IMC is used in therapeutics, the physicochemical 
information about its solubility is not abundant. On this way, it is well known that 
several physicochemical properties such as, the solubility of active ingredients and exci-
pients close to the respective occupied volumes in useful solutions, are very important 
for the pharmaceutical scientist, because they facilitate the processes associate to design 
and development of new products in the pharmaceutical industries (4). In view of the 
facts, there is considerable scope for the study the behavior of IMC in hydroalcoholic 
solutions. Taking into account that IMC is practically insoluble in water by the low 
polarity in comparison with that, the hydroalcoholic solution reduces the polarity of 
the medium and is expected then an increase of IMC solubility.
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 Figure 1. Molecular structure of indomethacin.
For these reasons, this report presents a physicochemical study about the solubility 
prediction of IMC in binary mixtures conformed by ethanol and water. The study was 
done based on the Extended Hildebrand Solubility Approach (EHSA), developed 
by Martin et al. to use it in pharmaceutical systems (5-7). As has been already descri-
bed, the solubility behavior of drugs in cosolvent mixtures is very important because 
cosolvent blends are frequently used in purification methods, preformulation studies, 
and pharmaceutical dosage forms design, among other applications (8, 9). This report 
expands the information presented about the solubility prediction of other analgesic 
drugs by means of EHSA method (10-14) including the one developed recently for 
this drug in ethyl acetate + ethanol mixtures (15).
Theoretical
The ideal solubility ( )2idX  of a solid solute in a liquid solution is calculated adequately 
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where, ∆Hfus is the fusion enthalpy of the solute, R is the universal gas constant (8.314 
J mol–1 K–1), Tfus is the melting point of the solute, and T is the absolute temperature 
of the solution. On the other hand, the real solubility (X2) is calculated by adding the 
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The 2 term is the activity coefficient of the solute and it must be determined experi-
mentally in the case of real solutions. Nevertheless, several techniques have been deve-
loped in order to obtain reasonable estimates of this term. One of these methods is 
the referent to regular solutions, in which, opposite to ideal solutions, a little positive 
enthalpic change is allowed (18). The solubility in regular solutions is obtained from,
− =
−( )












2 303 2 303
∆ 
   (Equation 3)
where, V2 is the partial molar volume of the solute (cm
3 mol–1), 1 is the volume frac-
tion of the solvent in the saturated solution, and 1 and 2 are the solubility para-
meters of solvent and solute, respectively. The solubility parameter, , is calculated 
as ( )/ /H RT Vv l−( )1 2, where, Hv is the vaporization enthalpy and Vl is the molar 
volume of the liquid.
The vast majority of pharmaceutical dissolutions deviate notoriously of that predic-
ted by the regular solutions theory (because of the strong interactions present, such 
as hydrogen bonding, in addition to the differences in molar volumes among solutes 
and solvents). On this way, at the beginning of the 80s of the past century, Martin 
et al. developed the EHSA method, which has been useful to estimate the solubility 
of several drugs in binary and ternary cosolvent systems (5-7). Accordingly, if the A 
term (defined as V RT2 1
2 2 303 /( . )) is introduced in the equation 3, the real solubility 
of drugs and other compounds in any solvent can be calculated from the expression,
− = − + + −( )log logX X A Wid2 2 12 22 2     (Equation 4)
where, the W term is equal to 2K12 (where, K is the Walker parameter, Ref. 16). The 
W factor compensates the deviations observed with respect to the behavior of regular 
solutions, and it can be calculated from experimental data by means of the following 
expression,











    (Equation 5)
where, 2 is the activity coefficient of the solute in the saturated solution, and it is cal-
culated as the quotient, X Xid2 2/ . 
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The experimental values obtained for the W parameter can be correlated by means of 
regression analysis by using regular polynomials in superior order as a function of the 
solubility parameter of the solvent mixtures, as follows,
W C C C C Cn




1   .....   (Equation 6)
These empiric models can be used to estimate the drug solubility by means of back-




Indomethacin [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid, 
CAS: 53-86-1] used was in agreement with the quality requirements indicated in the 
British Pharmacopoeia, BP (19). In similar way, absolute ethanol A.R. Merck (EtOH), 
distilled water with conductivity < 2 mS cm–1, and Millipore Corp. Swinnex®-13 filter 
units, were also used.
Solvent mixtures preparation
The dehydrated ethanol employed was maintained over molecular sieve (Merck Num-
ber 3, 0.3 nm in pore diameter) to obtain a dry solvent previously to prepare the solvent 
mixtures. The ethanol dryness was demonstrated by the respective density value obtai-
ned (0.7854 g cm–3 at 298.15 K), which was thus coincident with those reported in the 
literature (20, 21). All EtOH + water solvent mixtures were prepared in quantities of 
50.00 g by mass using an Ohaus Pioneer TM PA214 analytical balance with sensitivity 
± 0.1 mg, in mass fractions from 0.10 to 0.90 varying by 0.10, in order to study nine 
mixtures and both pure solvents.
Solubility determination
An excess of IMC was added to each cosolvent mixture evaluated in stoppered dark 
glass flasks. Solid-liquid mixtures were placed on a thermostatic bath (Neslab RTE 
10 Digital One Thermo Electron Company) kept at 298.15 ± 0.05 K with sporadic 
stirring for at least seven days to reach the saturation equilibrium (this equilibrium 
time was established by quantifying the IMC concentration up to obtain a constant 
value). In the case of neat water or water-rich mixtures the equilibration time was 14 
days. Once at equilibrium, supernatant solutions were filtered (at isothermal condi-
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tions) to remove insoluble particles before composition analysis. IMC concentrations 
in neat EtOH and the EtOH + W mixtures up to 0.40 in mass fraction of water were 
determined by mass balance by weighing a specified quantity of the respective satu-
rated solutions and allowing the solvent evaporation up to constant masses. In the 
other hand, IMC concentrations in all the other systems studied (from 0.50 in mass 
fraction of water to pure water) were determined by measuring UV-absorbance after 
appropriate gravimetric dilutions with ethanol and interpolation from a previously 
constructed UV spectrophotometric calibration curve (UV/VIS BioMate 3 Thermo 
Electron Company spectrophotometer). In order to make the equivalence between 
volumetric and gravimetric concentration scales, the density of the saturated solutions 
was determined with a digital density meter (DMA 45 Anton Paar) connected to the 
same recirculating thermostatic bath.
Estimation of the volumetric contributions 
Because the equations 3 to 5 require the volume contributions of each component to 
the saturated solution, in this investigation the IMC apparent specific volume ( V
spc ) 
was used to calculate these contributions. The V
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where, m2 and m1 are the masses of solute and solvent in the saturated solution, respec-
tively, VE1 is the specific volume of the solvent, and soln is the solution density. The 
IMC apparent molar volume is calculated by multiplying the V
spc value and the molar 
mass of the solute (357.8 g mol–1, Ref. 1). Otherwise, the calculated molar volume 
value obtained by means of the Fedors method was used in the later calculations and it 
was taken from the literature (230.0 cm3 mol–1, Ref. 15).
Results and Discussion
The information about polarity and volumetric behavior of EtOH + water mixtures as 
a function of the composition is shown in Table 1 and it was taken from the literature 
(13, 14, 23). It is important to note that the solubility parameter values of the solvent 
medium are in good agreement with those obtained from experimental permittivity 
data (24), which were thus calculated by using the Paruta equation (25). On the other 
hand, the calorimetric values reported in the literature for IMC were as follows, Tfus = 
432.6 K and H fus =
− 39 46 kJ mol 1.  (26). From these values the calculated ideal solubi-
lity for this drug was 7.123 × 10–3 in mole fraction (15). 
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Table 1 also summarizes the IMC solubility expressed in molarity and mole fraction, 
the density of the saturated mixtures, the apparent molar volume of IMC, and the sol-
vent volume fraction in the saturated solutions at 298.15 K. Figure 2 shows the expe-
rimental solubility and the calculated solubility by using the regular solution model 
(Equation 3) as a function of the solubility parameter of solvent mixtures. 
The IMC solubility is greater in EtOH but this value is lower than the obtained in the 
mixture of 0.6720 in volume fraction of ethyl acetate in mixtures conformed by ethyl 
acetate + EtOH (whose mixture has 1 = 20.86 MPa
1/2)(15).
Table 1. Solvent composition in volume fraction (without considering the solute), Hildebrand solu-
bility parameter of mixtures, IMC solubility expressed in mass percent and in mole fraction, density 
of the saturated mixtures, apparent molar volume of IMC, solvent volume fraction in the saturated 
solutions, and  activity coefficient of IMC as decimal logarithm, at 298.15 K.
ϕ  EtOH 1 /MPa1/2
IMC





1 log 2Mol L–1 X2
0.0000 47.80 5.16 × 10–5 9.32 × 10–7 0.9970 358.9 1.0000 3.883
0.1236 45.17 7.67 × 10–5 1.50 × 10–6 0.9806 –5395.6 1.0000 3.676
0.2409 42.67 1.44 × 10–4 3.06 × 10–6 0.9665 848.5 1.0000 3.367
0.3524 40.29 4.95 × 10–4 1.15 × 10–5 0.9516 –1111.8 0.9999 2.793
0.4584 38.04 1.77 × 10–3 4.53 × 10–5 0.9323 242.6 0.9996 2.197
0.5594 35.89 5.61 × 10–3 1.60 × 10–4 0.9121 –11.5 0.9987 1.649
0.6557 33.83 1.44 × 10–2 4.63 × 10–4 0.8892 246.9 0.9967 1.187
0.7476 31.88 2.89 × 10–2 1.06 × 10–3 0.8682 232.5 0.9934 0.829
0.8355 30.00 5.16 × 10–2 2.18 × 10–3 0.8469 248.5 0.9881 0.514
0.9195 28.21 6.86 × 10–2 3.40 × 10–3 0.8259 212.2 0.9842 0.322
1.0000 26.50 7.01 × 10–2 4.17 × 10–3 0.7966 249.8 0.9839 0.233
From density values of cosolvent mixtures (23) and saturated solutions (Table 1), in 
addition to IMC solubility (Table 1), the solvent volume fraction (1) and apparent 
molar volume of the solute V
mol( ) in the saturated mixtures, were calculated. These 
values are also presented in Table 1.
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Figure 2. Experimental solubility (o) and calculated solubility according to the regular solutions 
model of Hildebrand (◊) of IMC as a function of the solubility parameter of the solvent mixtures 
at 298.15 K.
In the literature (16, 17), the solute molar volume in the saturated solution has been 
considered as a constant value when EHSA method is used. On this way, for solid com-
pounds this property is generally calculated by means of groups’ contribution methods 
such as developed by Fedors (27). Nevertheless, this property is not independent on 
the solvent composition as can be see in Table 1 for apparent molar volume of IMC. 
This fact would be due to the different intermolecular interactions, depending on the 
respective solvent proportions. Nevertheless, the experimental values are variable and 
unclear, in particular for water-rich mixtures, where negative values were obtained. For 
this reason, in this investigation the calculated molar volume (230.0 cm3 mol–1, Ref. 
15) was employed in the following calculations. 
On the other hand, according to the literature (16, 17), the volume fraction of the sol-
vent mixture in the saturated solution has been calculated by means of the expression,
1
1 2






V X V X
( )
( )   (Equation 8)
Indomethacin solubility estimation by EHSA
87
where, V1 is the molar volume of the solvent (calculated for solvent mixtures as 







∑  , assuming additive volumes). Nevertheless, it is well known that the 
mixing volumes are not additives in those mixtures with strong presence of hydrogen 
bonding and great differences in molar volumes among their components. For this 
reason, the experimental volume fractions were used in this investigation for all the 
calculations involved (Table 1).
Ultimately, the activity coefficients of IMC as decimal logarithms are also presented in 
Table 1. These values were calculated from experimental solubility values (Table 1) and 
ideal solubility at 298.15 K (X2 = 7.123 × 10
–3). In all cases, γ2 values were greater than 
unit because the experimental solubilities are lower than the ideal one.
On the other hand, the parameters A, K, and W are presented in Table 2. In order to 
calculate the W parameter the experimental solubility parameter of IMC obtained in 
ethyl acetate + ethanol mixtures (20.86 MPa1/2) was used. This δ2 value is the same of 
the solvent mixture where the greatest drug solubility was found (15).
Table 2. A, K, and W experimental parameters for IMC in EtOH + water mixtures at 298.15 K.
1 / MPa
1/2 102 A / cm3 J–1 K / J cm–3 a W expt / J cm
–3 a
47.80 8.00566 0.669805 1335.736
45.17 8.00557 0.644585 1214.629
42.67 8.00532 0.621774 1106.832
40.29 8.00403 0.601957 1011.939
38.04 7.99933 0.584304 927.211
35.89 7.98519 0.568497 851.109
33.83 7.95285 0.554333 782.467
31.88 7.89986 0.541677 720.349
30.00 7.81695 0.530775 664.412
28.21 7.75536 0.521212 613.515
26.50 7.74964 0.513028 567.193
a 1 J cm–3 = 1 MPa
As has been already indicated, the W parameter accounts for the deviations presented 
by real solutions with respect to regular solutions. These deviations are mainly due to 
specific interactions such as hydrogen bonding.  IMC (Fig. 1) and both solvents stu-
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died can establish these interactions, as hydrogen donors or acceptors because of their 
polar moieties, in particular due to –OH groups.
Figure 3 shows that the variation of the W parameter with respect to the solubility 
parameter of solvent mixtures, presents deviation from linear behavior. W values were 
adjusted to regular polynomials in orders from 1 to 5 (equation 6) and their coeffi-
cients and statistical parameters are presented in the Table 3 (the empirical regressions 
were obtained by using MS Excel® and TableCurve 2D v5.01). The W values calculated 
by using the respective regular polynomials are presented in Table 4. It is well clear that 
these values depend on the model used in the W back-calculation. Similar behaviors 









Figure 3. Variation of the W parameter as a function of the solubility parameter of the solvent mix-
tures at 298.15 K.
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Table 3. Coefficients and statistical parameters of regular polynomials in several orders of W as a 
function of solubility parameters of cosolvent mixtures free of indomethacin (equation 6). Values in 




1 2 3 4 5
C0 –411 (36) 244 (12) 27 (16) 199 (88) 805 (611)
C1 35.8 (1.0) –0.9 (0.7) 17.4 (1.3) –2 (10) –87 (86)
C2 - 0.496 (0.009) –0.01 (0.04) 0.8 (0.4) 6 (5 )









C5 - - - - –1.0 (1.0)
× 10–5
r2 0.992 1.000 1.000 1.000 1.000
Fit. Err. 22.0 1.23 0.247 0.208 0.208




1 2 3 4 5
47.80 1298.735 1334.139 1335.694 1335.826 1335.780
45.17 1204.528 1215.139 1214.490 1214.308 1214.408
42.67 1115.141 1108.580 1107.252 1107.135 1107.112
40.29 1030.213 1013.069 1011.976 1012.013 1011.928
38.04 949.418 927.391 926.981 927.116 927.073
35.89 872.461 850.484 850.850 850.983 851.018
33.83 799.076 781.418 782.388 782.432 782.506
31.88 729.020 719.376 720.578 720.502 720.540
30.00 662.071 663.637 664.557 664.403 664.357
28.21 598.026 613.564 613.587 613.482 613.393
26.50 536.701 568.596 567.039 567.194 567.251
a 1 J cm–3 = 1 MPa
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Table 5 summarizes the solubility values obtained by using the W values obtained by 
back-calculation from the polynomial models presented in Table 4. Because we are 
searching the best adjust, the first criterion used to define the polynomial order of W 
as function of δ1 was the fitting standard uncertainties obtained, whose values were as 
follows, 22.0, 1.23, 0.247, 0.208, and 0.208 (Table 3), for orders one to five, respecti-
vely. As another comparison criterion, Table 5 also summarizes the percentages of diffe-
rence between IMC experimental solubility and those calculated by using EHSA.
Table 5. Calculated solubility of IMC by using the W parameters obtained from regression models 




X2 calculated % dev.
 a
1 2 3 4 5 1 2 3 4 5
47.80 1.11 × 10–11 5.17 × 10–7 9.17 × 10–7 9.63 × 10–7 9.47 × 10–7 100 44.5 1.6 3.4 1.6
45.17 3.62 × 10–8 1.81 × 10–6 1.43 × 10–6 1.33 × 10–6 1.38 × 10–6 98 20.7 5.0 11.2 7.8
42.67 6.55 × 10–5 5.83 × 10–6 3.57 × 10–6 3.42 × 10–6 3.39 × 10–6 2039 90.5 16.7 11.8 10.8
40.29 9.65 × 10–3 1.74 × 10–5 1.16 × 10–5 1.18 × 10–5 1.14 × 10–5 84091 51.7 1.4 2.7 0.4
38.04 0.162 4.84 × 10–5 4.16 × 10–5 4.37 × 10–5 4.31 × 10–5 357051 6.9 8.1 3.4 4.9
35.89 0.411 1.27 × 10–4 1.45 × 10–4 1.52 × 10–4 1.54 × 10–4 256954 20.5 9.1 4.5 3.3
33.83 0.203 3.15 × 10–4 4.49 × 10–4 4.57 × 10–4 4.69 × 10–4 43742 31.9 2.8 1.2 1.5
31.88 2.47 × 10–2 7.41 × 10–4 1.15 × 10–3 1.12 × 10–3 1.13 × 10–3 2244 29.8 8.7 5.7 7.2
30.00 9.40 × 10–4 1.65 × 10–3 2.30 × 10–3 2.18 × 10–3 2.14 × 10–3 57 24.4 5.3 0.3 2.0
28.21 1.34 × 10–5 3.46 × 10–3 3.49 × 10–3 3.36 × 10–3 3.25 × 10–3 100 1.8 2.6 1.2 4.3
26.50 7.83 × 10–8 6.88 × 10–3 3.94 × 10–3 4.17 × 10–3 4.26 × 10–3 100 65.0 5.4 0.0 2.1
Mean value b 67871 35.2 6.1 4.1 4.2
Standard Deviation b 123221 26.1 4.5 4.0 3.2
a Calculated as 100 ×X2 expt – X2 calc/X2 expt. 
(b) Calculated considering the obtained values in the neat solvents and 
the nine binary mixtures.
According to Table 5 it follows that, as more complex the polynomial used is, better 
the agreement found between experimental and calculated solubility is. This fact is 
confirmed based on the mean deviation percentages (4.1 % and 4.2 %, for orders 4 and 
5, respectively). In similar way to that found in other similar investigations (4-11), in 
this case, the most important increment in concordance is obtained passing from order 
1 to order 2 (from 67871 to 35.2 % as mean value), although significant increment is 
also obtained form order 2 to order 3 (from 35.2 to 6.1% as mean value). Thereby, in 
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the following calculations the model with lowest general deviation was used (order 4, 
Table 3).
An important consideration about the usefulness of the EHSA method is the one refe-
rent to justify the complex calculations involving any other variables of the considered 
system (Equation 4, Tables 1 to 4), instead of the simple empiric regression of the expe-
rimental solubility as a function of the solvent mixtures’ solubility parameters (Table 
1, Fig. 2). For this reason, in the Table 6 the experimental solubilities are confronted to 
those calculated directly by using a regular polynomial in order 4 of log X2 as a function 
of δ1 values (Equation 9, with determination coefficient r
2 = 0.999 and fitting standard 
uncertainty = 0.033) and also to those calculated involving the W parameters obtained 
from equation 6 adjusted to order 4 (Table 3). The respective difference percentages 
are also presented in Table 6.
log ( ) . ( . ) ( ) . ( . )X2 1
2
1
27 14 0 1 1 6 4 6 10 1 5 1 2= − − + × − ×− 
                10 1 0 0 8 103 1
3 5
1
4− −+ × . ( . )  (Equation 9)





Exptl. Calc. direct. b Calc. W c Calc. direct. Calc. W 
47.80 9.32 × 10–7 9.63 × 10–7 9.63 × 10–7 3.3 3.4
45.17 1.50 × 10–6 1.33 × 10–6 1.33 × 10–6 11.1 11.2
42.67 3.06 × 10–6 3.42 × 10–6 3.42 × 10–6 11.7 11.8
40.29 1.15 × 10–5 1.18 × 10–5 1.18 × 10–5 2.7 2.7
38.04 4.53 × 10–5 4.38 × 10–5 4.37 × 10–5 3.4 3.4
35.89 1.60 × 10–4 1.53 × 10–4 1.52 × 10–4 4.4 4.5
33.83 4.63 × 10–4 4.57 × 10–4 4.57 × 10–4 1.3 1.2
31.88 1.06 × 10–3 1.12 × 10–3 1.12 × 10–3 5.7 5.7
30.00 2.18 × 10–3 2.17 × 10–3 2.18 × 10–3 0.4 0.3
28.21 3.40 × 10–3 3.36 × 10–3 3.36 × 10–3 1.0 1.2
26.50 4.17 × 10–3 4.17 × 10–3 4.17 × 10–3 0.1 0.0
Mean value b 4.1 4.1
Standard Deviation b 4.0 4.0
a Calculated as 100 ×X2 expt – X2 calc/X2 expt. 
b Calculated using the equation 6 adjusted to order 4 (Table 3). c Calcu-
lated using the equation 9. d Calculated considering the obtained values in the neat solvents and the nine binary mixtures.
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Based on mean deviation percentages presented in Table 6 (4.1% and 4.1% for direct 
calculation and EHSA method, respectively) it follows that non-significant differences 
are found between the values obtained by using both methods. In similar way with 
that found for naproxen and ketoprofen (other analgesic drugs) in the same cosolvent 
system (13, 14), and for IMC in ethyl acetate + ethanol mixtures (15), the present 
results would be showing non-significant usefulness of EHSA method for practical 
purposes. The last point exposed would be a big controversial subject considering that 
EHSA method implies additional experimentation including density determinations 
and thermal characterization of the solid-liquid equilibrium for the solid compound. 
Nevertheless, it is necessary keep in mind that EHSA method considers the drug solu-
bility from a systematic physicochemical point of view. Moreover, it is just necessary 
to found an effective method to calculate the Walker K parameter in order to calculate 
the W term according to the expression 2Kδ1δ2, because the δ1 and δ2 terms would be 
known, and thus, the drug experimental solubility could be calculated in any mixture 
in particular.
Conclusion
In this investigation the EHSA method has been adequately used to study the solubi-
lity of IMC in EtOH + water mixtures by using experimental values of molar volume 
and Hildebrand solubility parameter of this analgesic drug. In particular, a good pre-
dictive character has been found by using a regular polynomial in order four of the 
interaction parameter W as a function of the solubility parameter of solvent mixtures 
free of solute. Form a practical viewpoint EtOH + water binary mixtures were thus 
constituted in good cosolvent systems for IMC, especially at higher fractions of alco-
hol, by generate a decrease on polarity of the medium.  
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